Acelrx Pharmaceuticals Inc
ACRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.58M
Close$
Share Statistics
| Market cap | $14.58 Million |
|---|---|
| Enterprise Value | $10.76 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.34 |
| Beta | 0.52 |
| Outstanding Shares | 69,821,593 |
Return
| Return on Equity | -77.13% |
|---|---|
| Return on Assets | -47.27% |
| Return on Invested Capital | -51.67% |
Valuation & Multiples
| P/E Ratio | -2.43 |
|---|---|
| PEG | 170.16 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 10755.98 |
| Enterprise Value to EBIT | -0.8 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Acelrx Pharmaceuticals Inc
CEO: Vincent Angotti